Literature DB >> 784927

Gentamicin and albumin-bilirubin binding. An in vivo study.

J T Woods, L E Bryan, G Chan, D Schiff.   

Abstract

Ten newborn infants were given gentamicin intramuscularly. Over a postinjection interval of 12 hours, no significant change occurred in the total binding capacity of serum albumin for bilirubin or in concentrations of serum bilirubin levels. There was no correlation between concentrations of serum gentamicin and the total binding capacity or serum bilirubin. This study provides in vivo data that supports recent in vitro experiments showing that gentamicin does not alter bilirubin-albumin binding.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 784927     DOI: 10.1016/s0022-3476(76)80559-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  5 in total

Review 1.  Glucose-6-Phosphate Dehydrogenase Deficiency and the Need for a Novel Treatment to Prevent Kernicterus.

Authors:  Anna D Cunningham; Sunhee Hwang; Daria Mochly-Rosen
Journal:  Clin Perinatol       Date:  2016-02-28       Impact factor: 3.430

Review 2.  Clinical pharmacokinetics of aminoglycoside antibiotics.

Authors:  J C Pechere; R Dugal
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

3.  Pharmacokinetics of gentamicin in very low birth weight preterm infants.

Authors:  K W Hindmarsh; R L Nation; G L Williams; E John; J N French
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  Evaluation of three antibiotic programs in newborn infants.

Authors:  S Marks; M I Marks; C Dupont; S Hammerberg
Journal:  Can Med Assoc J       Date:  1978-03-18       Impact factor: 8.262

Review 5.  Neonatal bilirubin toxicity. A review of kernicterus and the implications of drug-induced bilirubin displacement.

Authors:  P C Walker
Journal:  Clin Pharmacokinet       Date:  1987-07       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.